Overview

Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the efficacy, safety and tolerability of LAS41007 compared to a marketed reference product as well as to vehicle (topical application, twice daily, indication mild to moderate AK).
Phase:
Phase 3
Details
Lead Sponsor:
Almirall, S.A.